Executives are facing one of the most complicated planning environments over the past decade. We are excited to share our new Central Europe Healthcare report that now includes our expanded coverage on Czech Republic, Hungary, and Romania!
Follow along as we analyze procedure volumes, drug prices, pharmaceutical sales, and expenditures. We dive into the steps you should consider as you begin strategic planning for the year ahead and offer a watchlist for 2022-2023 in the current market of complex dynamics.
The governments of Central Europe countries are experiencing many pressure points, created by inflation, backlogs, and fiscal deficits. Some highlights from across the regions:
- In Czech Republic, the government is increasing funding for preventative care to boost return to pre-pandemic screening rates. Companies should expect increased procedure volumes, incidence rate, and demand for pharmaceuticals.
- In Poland, the government approved the Act on minimum wage increase to overcome staff shortage. However, the increase was uneven, leaving some healthcare workers protesting, which can affect procedure volumes and drug utilization.
- In Hungary, suppliers face uncertainty as healthcare expenditure and infrastructure development will be limited due to high debts and inflation.
- In Romania, companies are negotiating different types of financial contracts with the government to facilitate price increases. As significant price controls lead to one of the lowest prices for pharmaceuticals in the EU, inflation accelerates pricing pressure for pharmaceutical companies and lowers consumers’ purchasing power.
Download an Executive Summary of our Central Europe Healthcare Report
FrontierView is here to help your teams in aligning on a specific, actionable view on how inflation and restrained fiscal abilities will affect your business and how you can thrive despite external headwinds.
At FrontierView, our mission is to help our clients grow and win in their most important markets. We are excited to share that FiscalNote, a leading technology provider of global policy and market intelligence has acquired FrontierView. We will continue to cover issues and topics driving growth in your business, while fully leveraging FiscalNote’s portfolio within the global risk, ESG, and geopolitical advisory product suite.
Subscribe to our weekly newsletter The Lens published by our Global Economics and Scenarios team which highlights high-impact developments and trends for business professionals. For full access to our offerings, start your free trial today and download our complimentary mobile app, available on iOS and Android.